67 related articles for article (PubMed ID: 38512616)
21. THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy.
Chiloiro G; Cusumano D; Boldrini L; Romano A; Placidi L; Nardini M; Meldolesi E; Barbaro B; Coco C; Crucitti A; Persiani R; Petruzziello L; Ricci R; Salvatore L; Sofo L; Alfieri S; Manfredi R; Valentini V; Gambacorta MA
BMC Cancer; 2022 Jan; 22(1):67. PubMed ID: 35033008
[TBL] [Abstract][Full Text] [Related]
22. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
[TBL] [Abstract][Full Text] [Related]
23. Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions.
Hall WA; Small C; Paulson E; Koay EJ; Crane C; Intven M; Daamen LA; Meijer GJ; Heerkens HD; Bassetti M; Rosenberg SA; Aitken K; Myrehaug S; Dawson LA; Lee P; Gani C; Chuong MD; Parikh PJ; Erickson BA
Front Oncol; 2021; 11():628155. PubMed ID: 34046339
[TBL] [Abstract][Full Text] [Related]
24. Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis.
Chiloiro G; Meldolesi E; Giraffa M; Capocchiano ND; Barbaro B; Coco C; Corvari B; De Franco P; D'Ugo D; Alfieri S; Manfredi R; Valentini V; Gambacorta MA
Clin Transl Radiat Oncol; 2021 May; 28():1-9. PubMed ID: 33732909
[TBL] [Abstract][Full Text] [Related]
25. Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy.
Cusumano D; Boldrini L; Yadav P; Casà C; Lee SL; Romano A; Piras A; Chiloiro G; Placidi L; Catucci F; Votta C; Mattiucci GC; Indovina L; Gambacorta MA; Bassetti M; Valentini V
Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33466307
[TBL] [Abstract][Full Text] [Related]
26. Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials.
Gambacorta MA; Masciocchi C; Chiloiro G; Meldolesi E; Macchia G; van Soest J; Peters F; Collette L; Gérard JP; Ngan S; Rödel CC; Damiani A; Dekker A; Valentini V
Radiother Oncol; 2021 Jan; 154():154-160. PubMed ID: 32966845
[TBL] [Abstract][Full Text] [Related]
27. A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer.
Cusumano D; Meijer G; Lenkowicz J; Chiloiro G; Boldrini L; Masciocchi C; Dinapoli N; Gatta R; Casà C; Damiani A; Barbaro B; Gambacorta MA; Azario L; De Spirito M; Intven M; Valentini V
Radiol Med; 2021 Mar; 126(3):421-429. PubMed ID: 32833198
[TBL] [Abstract][Full Text] [Related]
28. External Validation of Early Regression Index (ERI
Cusumano D; Boldrini L; Yadav P; Yu G; Musurunu B; Chiloiro G; Piras A; Lenkowicz J; Placidi L; Broggi S; Romano A; Mori M; Barbaro B; Azario L; Gambacorta MA; De Spirito M; Bassetti MF; Yang Y; Fiorino C; Valentini V
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1347-1356. PubMed ID: 32758641
[TBL] [Abstract][Full Text] [Related]
29. Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration.
Broggi S; Passoni P; Gumina C; Palmisano A; Bresolin A; Burgio V; Di Chiara A; Elmore U; Mori M; Slim N; Ronzoni M; Rosati R; De Cobelli F; Di Muzio NG; Fiorino C
Radiother Oncol; 2020 Aug; 149():174-180. PubMed ID: 32417346
[TBL] [Abstract][Full Text] [Related]
30. The multidisciplinary management of rectal cancer.
Keller DS; Berho M; Perez RO; Wexner SD; Chand M
Nat Rev Gastroenterol Hepatol; 2020 Jul; 17(7):414-429. PubMed ID: 32203400
[TBL] [Abstract][Full Text] [Related]
31. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.
Zwanenburg A; Vallières M; Abdalah MA; Aerts HJWL; Andrearczyk V; Apte A; Ashrafinia S; Bakas S; Beukinga RJ; Boellaard R; Bogowicz M; Boldrini L; Buvat I; Cook GJR; Davatzikos C; Depeursinge A; Desseroit MC; Dinapoli N; Dinh CV; Echegaray S; El Naqa I; Fedorov AY; Gatta R; Gillies RJ; Goh V; Götz M; Guckenberger M; Ha SM; Hatt M; Isensee F; Lambin P; Leger S; Leijenaar RTH; Lenkowicz J; Lippert F; Losnegård A; Maier-Hein KH; Morin O; Müller H; Napel S; Nioche C; Orlhac F; Pati S; Pfaehler EAG; Rahmim A; Rao AUK; Scherer J; Siddique MM; Sijtsema NM; Socarras Fernandez J; Spezi E; Steenbakkers RJHM; Tanadini-Lang S; Thorwarth D; Troost EGC; Upadhaya T; Valentini V; van Dijk LV; van Griethuysen J; van Velden FHP; Whybra P; Richter C; Löck S
Radiology; 2020 May; 295(2):328-338. PubMed ID: 32154773
[TBL] [Abstract][Full Text] [Related]
32. Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An
Boldrini L; Placidi E; Dinapoli N; Azario L; Cellini F; Massaccesi M; Chiesa S; Gambacorta MA; Mattiucci GC; Piccari D; Teodoli S; De Spirito M; Valentini V
Tech Innov Patient Support Radiat Oncol; 2018 Jun; 6():5-10. PubMed ID: 32095572
[TBL] [Abstract][Full Text] [Related]
33. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
[TBL] [Abstract][Full Text] [Related]
34. "Après Mois, Le Déluge": Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era.
Kiser KJ; Smith BD; Wang J; Fuller CD
Front Oncol; 2019; 9():983. PubMed ID: 31632914
[TBL] [Abstract][Full Text] [Related]
35. MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology.
Chiloiro G; Boldrini L; Meldolesi E; Re A; Cellini F; Cusumano D; Corvari B; Mantini G; Balducci M; Valentini V; Gambacorta MA
Clin Transl Radiat Oncol; 2019 Sep; 18():80-86. PubMed ID: 31341981
[TBL] [Abstract][Full Text] [Related]
36. Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index.
Fiorino C; Passoni P; Palmisano A; Gumina C; Cattaneo GM; Broggi S; Di Chiara A; Esposito A; Mori M; Ronzoni M; Rosati R; Slim N; De Cobelli F; Calandrino R; Di Muzio NG
Clin Transl Radiat Oncol; 2019 Nov; 19():12-16. PubMed ID: 31334366
[TBL] [Abstract][Full Text] [Related]
37. Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy.
Bedin C; Crotti S; D'Angelo E; D'Aronco S; Pucciarelli S; Agostini M
Curr Med Chem; 2020; 27(25):4274-4294. PubMed ID: 31060482
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.
Kong JC; Guerra GR; Pham T; Mitchell C; Lynch AC; Warrier SK; Ramsay RG; Heriot AG
Dis Colon Rectum; 2019 Apr; 62(4):498-508. PubMed ID: 30844974
[TBL] [Abstract][Full Text] [Related]
39. Delta Radiomics Improves Pulmonary Nodule Malignancy Prediction in Lung Cancer Screening.
Alahmari SS; Cherezov D; Goldgof D; Hall L; Gillies RJ; Schabath MB
IEEE Access; 2018; 6():77796-77806. PubMed ID: 30607311
[TBL] [Abstract][Full Text] [Related]
40. Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach.
Boldrini L; Cusumano D; Chiloiro G; Casà C; Masciocchi C; Lenkowicz J; Cellini F; Dinapoli N; Azario L; Teodoli S; Gambacorta MA; De Spirito M; Valentini V
Radiol Med; 2019 Feb; 124(2):145-153. PubMed ID: 30374650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
